These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11096806)

  • 1. Celebrex (celecoxib).
    Claussen DW
    Gastroenterol Nurs; 2000; 23(1):43-4. PubMed ID: 11096806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
    Scheen AJ
    Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX 2-selective NSAIDs: biology, promises, and concerns.
    Mandell BF
    Cleve Clin J Med; 1999 May; 66(5):285-92. PubMed ID: 10330781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity.
    Juni P; Sterchi R; Dieppe P
    BMJ; 2003 Feb; 326(7384):334; author reply 334. PubMed ID: 12574052
    [No Abstract]   [Full Text] [Related]  

  • 5. New drug overview. Celecoxib.
    Am J Health Syst Pharm; 1999 May; 56(10):1031. PubMed ID: 10365731
    [No Abstract]   [Full Text] [Related]  

  • 6. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac.
    Goldstein JL; Eisen GM; Burke TA; Peña BM; Lefkowith J; Geis GS
    Aliment Pharmacol Ther; 2002 Apr; 16(4):819-27. PubMed ID: 11929402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib.
    Markowitz GS; Falkowitz DC; Isom R; Zaki M; Imaizumi S; Appel GB; D'Agati VD
    Clin Nephrol; 2003 Feb; 59(2):137-42. PubMed ID: 12608557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib for arthritis.
    Med Lett Drugs Ther; 1999 Jan; 41(1045):11-2. PubMed ID: 9949762
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective.
    Bessette L; Risebrough N; Mittmann N; Roussy JP; Ho J; Zlateva G
    J Med Econ; 2009 Sep; 12(3):246-58. PubMed ID: 19743942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib approved as NSAID with some concessions on class warning.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):403. PubMed ID: 10096694
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis.
    Cryer B; Luo X; Assaf AR; Sands G; Mardekian J
    Curr Med Res Opin; 2011 Feb; 27(2):295-302. PubMed ID: 21142617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis.
    McKenna F; Arguelles L; Burke T; Lefkowith J; Geis GS
    Clin Exp Rheumatol; 2002; 20(1):35-43. PubMed ID: 11892706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 16. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
    Jüni P; Rutjes AW; Dieppe PA
    BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Celecoxib].
    Caballero E; Cárdenas E; Rodrigo A; Gurucharri N; Honorato J
    Rev Med Univ Navarra; 2001; 45(1):56-9. PubMed ID: 11488208
    [No Abstract]   [Full Text] [Related]  

  • 18. Celecoxib clinical profile.
    Tive L
    Rheumatology (Oxford); 2000 Dec; 39 Suppl 2():21-8; discussion 57-9. PubMed ID: 11276798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Symptomatic therapy of arthrosis and rheumatoid arthritis. Who will benefit from Coxib?].
    MMW Fortschr Med; 2002 Apr; 144(14):53. PubMed ID: 12014284
    [No Abstract]   [Full Text] [Related]  

  • 20. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.